Lung Organotypic Slices Enable Rapid Quantification of Acute Radiotherapy Induced Toxicity

Author:

Dubail Maxime12ORCID,Heinrich Sophie12ORCID,Portier Lucie12ORCID,Bastian Jessica12,Giuliano Lucia3ORCID,Aggar Lilia12,Berthault Nathalie12,Londoño-Vallejo José-Arturo12,Vilalta Marta4,Boivin Gael4,Sharma Ricky A.45ORCID,Dutreix Marie12ORCID,Fouillade Charles12ORCID

Affiliation:

1. Institut Curie, Inserm U1021-CNRS UMR 3347, Paris Saclay University, Centre Universitaire, 91405 Orsay Cedex, France

2. Institut Curie, PSL Research University, 75006 Paris, France

3. SBAI Department, Sapienza University of Rome, 00161 Rome, Italy

4. Global Translational Science, Varian, a Siemens Healthineers Company, Palo Alto, CA 94304, USA

5. UCL Cancer Institute, University College London, London WC1E 6DD, UK

Abstract

To rapidly assess healthy tissue toxicities induced by new anti-cancer therapies (i.e., radiation alone or in combination with drugs), there is a critical need for relevant and easy-to-use models. Consistent with the ethical desire to reduce the use of animals in medical research, we propose to monitor lung toxicity using an ex vivo model. Briefly, freshly prepared organotypic lung slices from mice were irradiated, with or without being previously exposed to chemotherapy, and treatment toxicity was evaluated by analysis of cell division and viability of the slices. When exposed to different doses of radiation, this ex vivo model showed a dose-dependent decrease in cell division and viability. Interestingly, monitoring cell division was sensitive enough to detect a sparing effect induced by FLASH radiotherapy as well as the effect of combined treatment. Altogether, the organotypic lung slices can be used as a screening platform to rapidly determine in a quantitative manner the level of lung toxicity induced by different treatments alone or in combination with chemotherapy while drastically reducing the number of animals. Translated to human lung samples, this ex vivo assay could serve as an innovative method to investigate patients’ sensitivity to radiation and drugs.

Funder

INSERM

Varian, a Siemens Healthineers Company

Centre National de Recherche Scientifique, Institut Curie and Paris Saclay Unviersity

EMPIR program

European Union’s Horizon 2020 research and innovation program

Publisher

MDPI AG

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3